Home » Topics » BioWorld Science

BioWorld Science
RSS

New PARP inhibitors for acute brain infarction developed at Mitsubishi Pharma

May 26, 2004

Novel beta2-adrenoceptor agonist effective against bronchoconstriction in vivo

May 26, 2004

Oxigene updates Q1 development progress

May 26, 2004

Rigel initiates phase I/II trial for R-803 in HCV

May 26, 2004

Plenaxis commercialization and development progress

May 26, 2004

Initial NICE recommendations for Glivec rebutted by Novartis

May 26, 2004

AstraZeneca confirms safety of Crestor

May 26, 2004

Nadixa launched in Germany

May 26, 2004

Additional analysis of response data from phase III Dacogen study in MDS

May 26, 2004

Sinovac Biotech commences phase I testing of SARS vaccine

May 26, 2004

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...